T-independent responses to polysaccharides in humans mobilize marginal zone B cells prediversified against gut bacterial antigens.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
27 01 2023
Historique:
entrez: 27 1 2023
pubmed: 28 1 2023
medline: 1 2 2023
Statut: ppublish

Résumé

Marginal zone (MZ) B cells are one of the main actors of T-independent (TI) responses in mice. To identify the B cell subset(s) involved in such responses in humans, we vaccinated healthy individuals with Pneumovax, a model TI vaccine. By high-throughput repertoire sequencing of plasma cells (PCs) isolated 7 days after vaccination and of different B cell subpopulations before and after vaccination, we show that the PC response mobilizes large clones systematically, including an immunoglobulin M component, whose diversification and amplification predated the pneumococcal vaccination. These clones could be mainly traced back to MZ B cells, together with clonally related IgA

Identifiants

pubmed: 36706172
doi: 10.1126/sciimmunol.ade1413
pmc: PMC7614366
mid: EMS172514
doi:

Substances chimiques

Antigens, Bacterial 0
Pneumococcal Vaccines 0
Polysaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eade1413

Subventions

Organisme : European Research Council
ID : 693267
Pays : International

Commentaires et corrections

Type : CommentIn

Références

J Immunol. 2016 Jun 1;196(11):4723-30
pubmed: 27183571
J Allergy Clin Immunol. 2019 Apr;143(4):1575-1585.e4
pubmed: 30554723
J Exp Med. 2014 May 5;211(5):987-1000
pubmed: 24733829
Gut. 2014 Oct;63(10):1566-77
pubmed: 24436141
Infect Immun. 2002 Aug;70(8):4083-91
pubmed: 12117915
J Allergy Clin Immunol. 2005 Feb;115(2):412-7
pubmed: 15696104
Annu Rev Immunol. 1995;13:655-92
pubmed: 7612238
Ann N Y Acad Sci. 1995 Sep 29;764:370-3
pubmed: 7486548
Curr Opin Immunol. 1995 Jun;7(3):349-54
pubmed: 7546399
J Clin Invest. 1983 Apr;71(4):1032-40
pubmed: 6339558
Nat Immunol. 2002 Sep;3(9):822-9
pubmed: 12154359
Nat Commun. 2018 Sep 21;9(1):3857
pubmed: 30242242
J Exp Med. 2020 Mar 2;217(3):
pubmed: 31891367
Scand J Immunol. 1986 Feb;23(2):189-94
pubmed: 3513298
Immunology. 2004 Jan;111(1):1-7
pubmed: 14678191
J Infect Dis. 2010 Feb 15;201(4):516-24
pubmed: 20092407
Front Immunol. 2019 Mar 01;10:358
pubmed: 30881363
MAbs. 2017 Nov/Dec;9(8):1282-1296
pubmed: 28846502
Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22664-22672
pubmed: 31636219
J Immunol. 2007 Jul 1;179(1):13-9
pubmed: 17579014
Nat Immunol. 2022 Jul;23(7):1076-1085
pubmed: 35761085
Gut Microbes. 2020;11(2):217-230
pubmed: 31306081
J Infect Dis. 1998 Sep;178(3):870-4
pubmed: 9728562
Immunity. 2019 Aug 20;51(2):337-350.e7
pubmed: 31375460
Environ Microbiol Rep. 2016 Jun;8(3):399-406
pubmed: 27043715
J Immunol. 1977 Dec;119(6):1874-8
pubmed: 334975
Trends Immunol. 2005 Feb;26(2):85-9
pubmed: 15668123
Genetics. 2017 May;206(1):417-427
pubmed: 28315836
Eur J Immunol. 2000 Apr;30(4):1214-23
pubmed: 10760811
Lancet Infect Dis. 2007 Sep;7(9):597-606
pubmed: 17714673
J Exp Med. 2008 Jun 9;205(6):1331-42
pubmed: 18519648
Sci Transl Med. 2021 Apr 14;13(589):
pubmed: 33853929
Science. 2003 Sep 5;301(5638):1374-7
pubmed: 12920303
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8
pubmed: 18503082
Immunity. 2002 Sep;17(3):341-52
pubmed: 12354386
Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1166-70
pubmed: 11158612
Immunobiology. 2013 May;218(5):745-54
pubmed: 23084371
J Am Chem Soc. 2018 Apr 18;140(15):5202-5210
pubmed: 29578688
Nat Immunol. 2011 Dec 25;13(2):170-80
pubmed: 22197976
Pediatr Infect Dis J. 2007 Aug;26(8):716-22
pubmed: 17848884
Bioinformatics. 2014 Jul 1;30(13):1930-2
pubmed: 24618469
Semin Immunol. 2004 Aug;16(4):277-81
pubmed: 15522625
J Exp Med. 2009 Nov 23;206(12):2659-69
pubmed: 19917772
Cell Rep. 2019 Apr 9;27(2):572-585.e7
pubmed: 30970259
J Immunol Methods. 2008 Jan 1;329(1-2):112-24
pubmed: 17996249
J Immunol. 2015 Aug 15;195(4):1417-26
pubmed: 26150533
J Exp Med. 2021 Apr 5;218(4):
pubmed: 33538776
J Exp Med. 2022 Mar 7;219(3):
pubmed: 35230385
J Immunol. 2015 Oct 15;195(8):3716-24
pubmed: 26355154
AIDS Res Hum Retroviruses. 2008 Apr;24(4):621-33
pubmed: 18426338
Bioinformatics. 2015 Oct 15;31(20):3356-8
pubmed: 26069265
Nat Protoc. 2016 Aug;11(8):1531-53
pubmed: 27466712
Blood. 2004 Dec 1;104(12):3647-54
pubmed: 15191950
J Immunol. 2008 Oct 15;181(8):5306-12
pubmed: 18832686
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32640466
Infect Immun. 2004 Jun;72(6):3505-14
pubmed: 15155658
Cell. 2021 May 27;184(11):2955-2972.e25
pubmed: 34019795
Nat Rev Immunol. 2012 Jun 25;12(7):517-31
pubmed: 22728528
BMC Infect Dis. 2018 Dec 4;18(1):613
pubmed: 30509199
Ann N Y Acad Sci. 2015 Dec;1362:98-109
pubmed: 25930711
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5281-9
pubmed: 26324941
Curr Opin Immunol. 2011 Jun;23(3):330-6
pubmed: 21482090
Expert Rev Vaccines. 2021 Mar;20(3):257-267
pubmed: 33567914
Aging Cell. 2011 Dec;10(6):922-30
pubmed: 21726404
Blood. 2014 Dec 4;124(24):3561-71
pubmed: 25320238
J Microbiol Methods. 2001 Nov;47(2):135-49
pubmed: 11576678
J Exp Med. 2003 Apr 7;197(7):939-45
pubmed: 12682112
Nat Rev Immunol. 2009 Mar;9(3):185-94
pubmed: 19240757
Vaccine. 2020 Oct 14;38(44):6859-6863
pubmed: 32896468
Immun Ageing. 2005 Jun 27;2:10
pubmed: 15982420
Immunol Cell Biol. 2015 Nov;93(10):885-95
pubmed: 25976772
Infect Immun. 2001 Feb;69(2):853-64
pubmed: 11159978
Immunol Rev. 2000 Aug;176:154-70
pubmed: 11043775
Clin Exp Immunol. 1986 Jan;63(1):127-34
pubmed: 3955880
J Immunol. 2007 Jun 15;178(12):8212-20
pubmed: 17548660
Immunity. 2001 May;14(5):617-29
pubmed: 11371363
J Exp Med. 2022 Mar 7;219(3):
pubmed: 35019947
J Immunol. 2012 Mar 1;188(5):2455-63
pubmed: 22271652
J Immunol. 1990 May 15;144(10):3770-8
pubmed: 2110213
J Exp Med. 2006 Feb 20;203(2):305-10
pubmed: 16476769
Immunol Rev. 2020 Jul;296(1):36-47
pubmed: 32557712
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
Eur J Immunol. 1999 Oct;29(10):3216-24
pubmed: 10540333

Auteurs

Sandra Weller (S)

Université Paris Cité, INSERM U1151, CNRS UMR-8253, Institut Necker Enfants Malades (INEM), F-75015 Paris, France.

Delphine Sterlin (D)

Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), F-75013 Paris, France.
Département d'Immunologie, Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, F-75013 Paris, France.

Tatiana Fadeev (T)

Université Paris Cité, INSERM U1151, CNRS UMR-8253, Institut Necker Enfants Malades (INEM), F-75015 Paris, France.

Eva Coignard (E)

Université Paris Cité, INSERM U1151, CNRS UMR-8253, Institut Necker Enfants Malades (INEM), F-75015 Paris, France.

Alba Verge de Los Aires (A)

Université Paris Cité, INSERM U1151, CNRS UMR-8253, Institut Necker Enfants Malades (INEM), F-75015 Paris, France.

Clara Goetz (C)

Université Paris Cité, INSERM U1151, CNRS UMR-8253, Institut Necker Enfants Malades (INEM), F-75015 Paris, France.

Rémi Fritzen (R)

Université Paris Cité, INSERM U1151, CNRS UMR-8253, Institut Necker Enfants Malades (INEM), F-75015 Paris, France.
School of Medicine, University of St Andrews, St Andrews, UK.

Mathilde Bahuaud (M)

Université Paris Cité, INSERM U1016, Institut Cochin, F-75014 Paris, France.
Service d'Immunologie Biologique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, F-75014 Paris, France.

Frederic Batteux (F)

Université Paris Cité, INSERM U1016, Institut Cochin, F-75014 Paris, France.
Service d'Immunologie Biologique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, F-75014 Paris, France.

Guy Gorochov (G)

Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), F-75013 Paris, France.
Département d'Immunologie, Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, F-75013 Paris, France.

Jean-Claude Weill (JC)

Université Paris Cité, INSERM U1151, CNRS UMR-8253, Institut Necker Enfants Malades (INEM), F-75015 Paris, France.

Claude-Agnès Reynaud (CA)

Université Paris Cité, INSERM U1151, CNRS UMR-8253, Institut Necker Enfants Malades (INEM), F-75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH